Publication
Number of items: 3.
26 March 2024
  • Responsiveness and minimal important change of the Family Reported Outcome Measure (FROM-16). (2024) R. Shah, A.Y. Finlay, M.S. Salek, H. Allen, S.J. Nixon, M. Nixon, K. Otwombe, F.M. Ali and J.R. Ingram
    • 9 November 2023
  • Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial. (2023) David A. Andrae, RF Grace, Adrian Jewett, Brandon Foster, Robert J. Klaassen, Sam Salek, Junlong Li, Feng Tai, Audra N. Boscoe and Erin Zagadailov
    • 6 June 2023
  • Hyperhidrosis quality of life index (HidroQoL): further validation by applying classical test theory and item response theory using data from a phase III clinical trial. (2023) Theresa Donhauser, Christian Apfelbacher, Gesina Kann, Clarissa Masur, Paul Kamudoni, Sam Salek, Christoph Abels and Michaela Gabes